|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
BullFrog AI Launches Global Sales of BullFrog Data Networks™ with Sygnature Discovery, Targeting Up to $30M Revenue Opportunity
BullFrog AI (Nasdaq: BFRG) has officially kicked off commercial sales of its BullFrog Data Networks™ platform through a global partnership with Sygnature Discovery. With a projected revenue opportunity of $15–$30 million through 2028, the AI-powered solution is now being marketed to Sygnature’s extensive biopharma client base, offering cutting-edge tools for early target discovery, clinical trial optimization, and data-driven drug development.
|
|
|
|
New Era Energy Hits Major Milestone with Phase One Completion at 1GW AI Data Center Campus
New Era Energy & Digital (Nasdaq: NUAI) has completed Phase One engineering for its flagship AI-focused data center project in the Permian Basin, a 1-gigawatt campus developed through its 50/50 JV with Sharon AI. Backed by environmental clearances and feasibility validations, the project is on track for power delivery in early 2027—positioning New Era to meet the explosive demand for AI infrastructure with a vertically integrated model that lowers tenant costs and accelerates deployment.
|
|
|
|
|
Jackpot Digital Secures Mississippi Gaming License, Expanding U.S. Footprint
Jackpot Digital (OTCQB: JPOTF; TSXV: JJ) has been granted a Manufacturer and Distributor License by the Mississippi Gaming Commission, paving the way for deployment of its flagship dealerless poker platform, Jackpot Blitz®, across the $2.4B Mississippi gaming market. This marks the company’s second U.S. state-level license and signals accelerating adoption of its digital poker tables by leading land-based casinos in one of the nation’s top gaming destinations.
|
|
|
|
|
|
|
NioCorp Prices $60M U.S. Public Offering to Advance Elk Creek Critical Minerals Project
NioCorp Developments (Nasdaq: NB) has priced a $60 million public offering of common shares at $6.15 per share, with proceeds earmarked to support working capital and move its Elk Creek Project toward construction and commercial operation. Positioned to produce high-value critical minerals like niobium, scandium, titanium, and rare earths, the Elk Creek Project is a cornerstone in NioCorp’s strategy to address rising global demand for strategic materials.
|
|
|
|
|
Phoenix Motor Expands Crypto Payments and Launches Treasury Plan to Boost EV Sales & Digital Integration
Phoenix Motor (OTC: PEVM) has expanded its EdisonFuture subsidiary’s payment options to include Ethereum, BNB, and Solana, alongside Bitcoin, and unveiled a crypto treasury management strategy to optimize digital asset use. This move enhances flexibility for electric vehicle and EFaaS customers while positioning Phoenix at the forefront of fintech integration in the zero-emission commercial transport space.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Foremost Clean Energy Ltd. (NASDAQ: FMST)& Aptevo Therapeutics Inc.(NASDAQ: APVO)
|
|
|
|
|
|
|
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates

| Company |
Rating |
Price Target |
Firm |
Report Date |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 29, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7.5 |
Northland Securities |
July 23, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$4 |
Titan Partners |
July 17, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$5 |
Maxim |
July 10, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7 |
H.C. Wainwright |
July 9, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 9, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$4 |
HC Wainwright |
July 2, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
July 1, 2025 |
| Lantern Pharma (Nasdaq: LTRN) |
Buy |
$25 |
Lake Street |
June 17, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Craig Hallum |
June 5, 2025 |
| Creative Medical (Nasdaq: CELZ) |
Buy |
$8 |
Roth |
June 4, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$8 |
ThinkEquity |
June 2, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7.25 |
Ascendiant Capital |
April 20, 2025 |
| Enlivex Therapeutics (NASDAQ: ENLV) |
Buy |
$7 |
H.C. Wainwright |
March 24, 2025 |
| BioVie (Nasdaq: BIVI) |
Buy |
$6 |
Brookline |
March 18, 2025 |
| Lantern Pharma (Nasdaq: LTRN) |
Buy |
$15 |
ThinkEquity |
March 17, 2025 |
| Jupiter Neurosciences (Nasdaq: JUNS) |
Buy |
$30 |
Greenridge Global |
March 6, 2025 |
| Fathom Holdings (NASDAQ: FTHM) |
Buy |
$3.75 |
Roth |
March 3, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
February 25, 2025 |
| Enlivex Therapeutics (NASDAQ: ENLV) |
Buy |
$13 |
D. Boral |
February 7, 2025 |
| Gorilla Technology Group (NASDAQ: GRRR) |
Buy |
$18 |
Northland Capital Markets |
January 22, 2025 |
| Gorilla Technology Group (NASDAQ: GRRR) |
Buy |
$3 |
ThinkEquity |
January 13, 2025 |
| Gorilla Technology Group (NASDAQ: GRRR) |
Buy |
$27 |
Alliance Global Partners |
January 2, 2025 |
|

|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
Enlivex Therapeutics (NASDAQ: ENLV)
10:00am Eastern
Join Jason Kolbert, Managing Director of Healthcare Research at D. Boral Capital and Dr. Roger Pomerantz, M.D. & Vice Chairman of Enlivex Therapeutics for an exclusive virtual panel discussion featuring Professor Philip Conaghan MBBS, PhD, FRACP, FRCP, a leading clinician scientist working in the field of musculoskeletal medicine and Professor Ali Mobasheri BSc, ARCS, MSc, DPhil (Oxon), a leading scientist working in the area of musculoskeletal biology.
|
|
|
|
BioVie (NASDAQ: BIVI)
4:15pm Eastern
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's disease, Parkinson’s disease and long COVID) and advanced liver disease. In neurodegenerative disease, the Company’s lead drug candidate bezisterim inhibits the production of tumor necrosis factor alpha (TNF-α) to reduce neuroinflammation and insulin resistance – both of which are drivers of Alzheimer’s and Parkinson’s.
|
|
|
|
Archived Events
|
|
|
NioCorp Developments (NASDAQ: NB)
4:15pm Eastern
NioCorp is developing the Elk Creek Project that is expected to produce niobium, scandium, and titanium.
|
|
|
|
Quote of the Week
|
"Our approach to investing in small- and micro-cap companies is successful because it focuses on what matters when trying to value individual companies within the context of ever-changing investor tastes: seeing past the noise of what is popular at the moment and identifying value with independent judgment."
|
|
|
— Punch & Associates Investment Management Inc
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Mitigate risk in small-caps by buying a basket of stocks.
|
|
|
|
|
|
|